moxonidine has been researched along with malondialdehyde in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dhalla, KS; Dhalla, NS; Rupp, H | 1 |
| Gupta, S; Sharma, B | 1 |
2 other study(ies) available for moxonidine and malondialdehyde
| Article | Year |
|---|---|
Mechanisms of cardiac cell damage due to catecholamines: significance of drugs regulating central sympathetic outflow.
Topics: Analysis of Variance; Animals; Antihypertensive Agents; Blood Pressure; Calcium; Catecholamines; Clonidine; Disease Models, Animal; Heart; Heart Rate; Hypertension; Imidazoles; Isoproterenol; Lipid Peroxidation; Male; Malondialdehyde; Myocardium; Oxidation-Reduction; Rats; Rats, Inbred SHR; Rats, Sprague-Dawley; Sarcolemma; Sarcoplasmic Reticulum; Vitamin E | 1994 |
Pharmacological modulation of I(1)-imidazoline and α2-adrenoceptors in sub acute brain ischemia induced vascular dementia.
Topics: Acetylcholinesterase; Adrenergic alpha-2 Receptor Agonists; Animals; Brain; Brain Ischemia; Catalase; Clonidine; Dementia, Vascular; Glutathione; Imidazoles; Imidazoline Receptors; Learning Disabilities; Malondialdehyde; Maze Learning; Memory Disorders; Mice; Receptors, Adrenergic, alpha-2; Superoxide Dismutase | 2014 |